LIS Technologies Inc, a proprietary developer of advanced laser technology and the only US-origin patented laser uranium enrichment company, has closed a $17 million funding round that was oversubscribed by 240%. The raise was led by a single large accredited investor, with strong participation from returning advanced nuclear technology investors and company insiders.
The round was expanded due to overwhelming demand, reflecting high investor confidence in the company’s vision, its world-class technical team and executive leadership recruited from ASML, nuclear technology entrepreneurs and former US national leaders. LIS Technologies’ technology remains the only patented laser uranium enrichment solution of US origin.
The funding also reflects growing momentum in the advanced nuclear energy sector and LIST’s role in supporting Department of Energy (DOE) objectives as the US rebuilds its nuclear fuel supply chain. Following the company’s receipt of a Radioactive Material Licence from the State of Tennessee, LIST can now procure uranium hexafluoride (UF₆) feedstock and accelerate research, development and optimisation towards deployment of a commercial laser enrichment facility in the United States. An announcement on the enrichment facility and site is expected shortly.
“LIS Technologies continues to attract exceptional investor support, resulting in our fourth consecutive oversubscribed funding round,” said Jay Yu, Executive Chairman and CEO of LIS Technologies Inc. “This backing reflects confidence in our management, mission and technology, and in our belief that 2026 will be a transformative year for the company. The funding allows us to accelerate our growth plan and advance the third generation of laser enrichment technology to support today’s reactors, emerging SMRs and microreactors and the wider nuclear energy sector.”
LIS Technologies is one of six domestic US companies awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract by DOE in 2024 under the up to $3.4 billion Low-Enriched Uranium (LEU) Enrichment Acquisition Programme. The contracts run for up to 10 years and are designed to rebuild the US nuclear fuel supply chain.
“The LIST team is proud of this successful raise and we believe our laser enrichment technology will be the first in the world to scale commercially,” said Christo Liebenberg, President and Co-Founder of LIS Technologies. “Once commercialised, enrichment costs will fall significantly and LIST will strengthen US energy security and domestic nuclear capability. The funds will support optimisation at our Test Demonstration Facility, hardware scaling, site preparation for a commercial facility and expansion of our expert team.”
The funding will also enable LIST to demonstrate single-stage LEU production, two-stage HALEU production and to expand CRISLA into stable and medical isotope markets using fully industrialised equipment.
Find more stories like this here…